Abstract
CLINICAL DEMENTIA RATING-SUM OF BOXES RESPONDER ANALYSIS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI-AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Paper Title
Journal
Date
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
